Aveanna Healthcare Holdings Future Growth
Future criteria checks 3/6
Aveanna Healthcare Holdings is forecast to grow earnings and revenue by 110.3% and 4.9% per annum respectively while EPS is expected to grow by 106.9% per annum.
Key information
110.3%
Earnings growth rate
106.9%
EPS growth rate
| Healthcare earnings growth | 20.7% |
| Revenue growth rate | 4.9% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 03 Dec 2024 |
Recent future growth updates
Aveanna Healthcare Holdings Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates
Aug 11
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 12Recent updates
We Like These Underlying Return On Capital Trends At Aveanna Healthcare Holdings (NASDAQ:AVAH)
Dec 14Aveanna Healthcare Holdings Inc.'s (NASDAQ:AVAH) Price Is Right But Growth Is Lacking After Shares Rocket 25%
Nov 08Aveanna Healthcare Holdings Inc.'s (NASDAQ:AVAH) Shares Bounce 45% But Its Business Still Trails The Industry
Sep 01Aveanna Healthcare Holdings Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates
Aug 11Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Shares Fly 35% But Investors Aren't Buying For Growth
Jul 18Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 12Investors Aren't Buying Aveanna Healthcare Holdings Inc.'s (NASDAQ:AVAH) Revenues
Apr 15An Intrinsic Calculation For Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Suggests It's 47% Undervalued
Jan 23Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Surges 64% Yet Its Low P/S Is No Reason For Excitement
Dec 11Aveanna Healthcare Holdings Inc. Just Reported A Surprise Profit And Analysts Updated Their Estimates
Aug 13Capital Allocation Trends At Aveanna Healthcare Holdings (NASDAQ:AVAH) Aren't Ideal
Jul 20Some Investors May Be Worried About Aveanna Healthcare Holdings' (NASDAQ:AVAH) Returns On Capital
Mar 14Aveanna Healthcare Holdings' (NASDAQ:AVAH) Returns On Capital Not Reflecting Well On The Business
Nov 13Aveanna Healthcare - In Need Of Help
Sep 26Aveanna Healthcare Holdings Non-GAAP EPS of $0.03 misses by $0.04, revenue of $443M misses by $4.02M
Aug 11Aveanna Healthcare cuts 2022 guidance, expects weak Q2 results due to labor issues
Jul 19Aveanna Contends With Labor And Supply Chain Challenges In Inflationary Environment
Jun 21Aveanna Healthcare Holdings (NASDAQ:AVAH) Could Be Struggling To Allocate Capital
Jun 15Aveanna Healthcare: I Still Can't Care For It
Jan 27Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 2,214 | 31 | 3 | 31 | 7 |
| 12/31/2025 | 2,104 | 18 | 43 | 36 | 8 |
| 12/31/2024 | 2,004 | -37 | 11 | 19 | 7 |
| 9/28/2024 | 1,983 | -66 | 10 | 16 | N/A |
| 6/29/2024 | 1,952 | -125 | 10 | 16 | N/A |
| 3/30/2024 | 1,919 | -114 | -2 | 3 | N/A |
| 12/30/2023 | 1,895 | -135 | 14 | 23 | N/A |
| 9/30/2023 | 1,868 | -347 | -25 | -15 | N/A |
| 7/1/2023 | 1,833 | -220 | -34 | -22 | N/A |
| 4/1/2023 | 1,804 | -719 | -44 | -31 | N/A |
| 12/31/2022 | 1,788 | -662 | -60 | -48 | N/A |
| 10/1/2022 | 1,751 | -550 | -56 | -42 | N/A |
| 7/2/2022 | 1,719 | -573 | -43 | -27 | N/A |
| 4/2/2022 | 1,712 | -98 | -5 | 12 | N/A |
| 1/1/2022 | 1,679 | -117 | -27 | -11 | N/A |
| 10/2/2021 | 1,687 | -1 | 7 | 21 | N/A |
| 7/3/2021 | 1,642 | -10 | 16 | 26 | N/A |
| 4/3/2021 | 1,557 | -89 | 28 | 40 | N/A |
| 1/2/2021 | 1,495 | -57 | 101 | 117 | N/A |
| 12/28/2019 | 1,384 | -77 | -25 | -9 | N/A |
| 12/29/2018 | 1,254 | -47 | 2 | 22 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AVAH is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: AVAH is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: AVAH is expected to become profitable in the next 3 years.
Revenue vs Market: AVAH's revenue (4.9% per year) is forecast to grow slower than the US market (9.1% per year).
High Growth Revenue: AVAH's revenue (4.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if AVAH's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 02:01 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/28 |
| Annual Earnings | 2023/12/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Aveanna Healthcare Holdings Inc. is covered by 12 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Steven Valiquette | Barclays |
| Sarah James | Barclays |
| Matthew Borsch | BMO Capital Markets Equity Research |